Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NextLinx was a leading provider of global trade management (GTM) software and services, specifically catering to highly regulated industries such as life sciences, pharmaceuticals, and healthcare. The company's solutions automated the complex regulatory requirements associated with the international movement of goods, including the import and export of biological samples, controlled substances, and medical devices. By providing real-time trade content and compliance automation, NextLinx helped life science organizations navigate global customs regulations and ensure supply chain integrity. The company was acquired by Management Dynamics in 2005, which was later integrated into Amber Road and subsequently E2open.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NextLinx.